CPH Share Price Up on Completed Halucenex Acquisition (ASX:CPH)
The Creso Pharma [ASX:CPH] share price jumped 8% after completing the acquisition of Canadian psychedelics company Halucenex Life Sciences.

The Creso Pharma [ASX:CPH] share price jumped 8% after completing the acquisition of Canadian psychedelics company Halucenex Life Sciences.
By Lachlann Tierney,

In today’s Money Weekend…high risk for high reward…ignorance is bliss…a few biotech stocks for your watchlist…and more…
By Murray Dawes,

The MGC Pharmaceuticals [ASX:MXC] cannabis-derived epilepsy product is set to be fully covered by the HSE in Ireland.
By Lachlann Tierney,

The Creso Pharma Ltd [ASX:CPH] share price jumped 12% after the pot stock completed its US OTC dual listing. CPH shares were up as much as 15% in early trade…
By Lachlann Tierney,

Aspiring pill-packer Probiotec Ltd [ASX:PBP] share price is up 7.18% today, rising on the back of upgraded guidance from management…

The Creso Pharma [ASX:CPH] share price rose today after acquisition target Halucenex expands clinical trial recruitment.
By Lachlann Tierney,
Investment ideas from the edge of the bell curve.
Go beyond conventional investing strategies with unique ideas and actionable opportunities. Our expert editors deliver conviction-led insights to guide your financial journey.
All advice is general in nature and has not taken into account your personal circumstances. Please seek independent financial advice regarding your own situation, or if in doubt about the suitability of an investment.
The value of any investment and the income derived from it can go down as well as up. Never invest more than you can afford to lose and keep in mind the ultimate risk is that you can lose whatever you’ve invested. While useful for detecting patterns, the past is not a guide to future performance. Some figures contained in our reports are forecasts and may not be a reliable indicator of future results. Any actual or potential gains in these reports may not include taxes, brokerage commissions, or associated fees.
Fat Tail Daily is brought to you by the team at Fat Tail Investment Research
Copyright © 2026 Fat Tail Daily | ACN: 117 765 009 / ABN: 33 117 765 009 / ASFL: 323 988